ARUNJYOTI BIO VENTURES
|
|
| BOM : 530881     NSE :      | |
| LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Oct 30,2026 |
|
Price(EOD): ₹ 4.16
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Finance - Investment |
| MCap: ₹ 77.54 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ARUNJYOTI BIO VENTURES | 5.3% | 3% | -69.3% |
| BAJAJ FINSERV | -0.4% | -4.4% | -22.6% |
| AUTHUM INVESTMENT & INFRASTRUCTURE | 1.4% | -8.7% | -17.3% |
| CHOLAMANDALAM FINANCIAL HOLDINGS | 7.9% | -1.7% | -32.3% |
| TVS HOLDINGS | 10% | -2.1% | -24% |
| CAPRI GLOBAL CAPITAL | -0.1% | -6.6% | 12.9% |
| JSW HOLDINGS | -3.7% | -1% | -33.3% |
| MAHARASHTRA SCOOTERS | -2% | -9.3% | -32.1% |
| JM FINANCIAL | 0.5% | -14.2% | -33.5% |
FUNDAMENTAL ANALYSIS OF ARUNJYOTI BIO VENTURES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ARUNJYOTI BIO VENTURES
 | Ratio | Standalone | |
|---|---|---|
|
P/E P/B P/S |
-12.99
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -5.97 Cr
[Latest Qtr - Jun2026 - Standalone Results ] 2.7
P/B Calculated based on Book Value of Rs 28.72 Cr
[Latest Year - Mar2026 - Standalone Results ] 2.85
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2026 - Standalone Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-54% 29% 59% |
SHARE PRICE MOMENTUM OF ARUNJYOTI BIO VENTURES
ARUNJYOTI BIO VENTURES vs SENSEX
DEBT OF ARUNJYOTI BIO VENTURES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2026 2025 2024 Avg_3yrs |
0.76 0.77 28.73 10.09 |
- - - - |
|
[Last Annual Data : Mar2026]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF ARUNJYOTI BIO VENTURES
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Sep2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF ARUNJYOTI BIO VENTURES
| Standalone | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
13.31% 187.41% 112.98% 111.33% |
-5.88% -42.07% -62.29% -70.07% |
| QtrlyTrend |
0 | |
| Latest Qtr: Jun2026 | ||
| Quarterly Result Analysis → | ||
ARUNJYOTI BIO VENTURES related INDICES
You may also like the below Video Courses
FAQ about ARUNJYOTI BIO VENTURES
Is ARUNJYOTI BIO VENTURES good for long term investment?
As on Oct 30,2026, the Fundamentals of ARUNJYOTI BIO VENTURES look Poor and hence it may not be good for long term investment ! See Financial Performance of ARUNJYOTI BIO VENTURES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ARUNJYOTI BIO VENTURES UnderValued or OverValued?
As on Oct 30,2026, ARUNJYOTI BIO VENTURES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ARUNJYOTI BIO VENTURES ?
As on Oct 30,2026, the Intrinsic Value of ARUNJYOTI BIO VENTURES is Rs. 3.22 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 9.13
Fair Value [Median EV / Sales Model] : Rs. 3.22
Fair Value [Median Price / Sales Model] : Rs. 2.61
Estimated Median Fair Value of ARUNJYOTI BIO VENTURES : Rs. 3.22
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.